Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › FDA Stepping Up Actions Against PGx Testing, Forcing Some Labs to Stop Reporting Drug Information

FDA Stepping Up Actions Against PGx Testing, Forcing Some Labs to Stop Reporting Drug Information

Aug 16, 2019
|
Turna Ray

NEW YORK – The US Food and Drug Administration last month intensified regulatory actions against labs offering pharmacogenetics services without premarket clearance or approval in an apparent attempt to prod more firms to submit their tests for regulatory review.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  2. FDA Approves Avioq's Supplemental HIV Test

  3. Scopio Labs Receives FDA 510(k) Clearance for Automated Hematology Platform

  4. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  5. LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.